Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05157113 · ClinicalTrials.gov registry record · Phase 4
Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population
A Phase 4 study of Surgery and Cataract, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT05157113 is a Phase 4 study of Surgery and Cataract that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 70 participants, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05157113, a Phase 4 study of Surgery and Cataract, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The current postoperative cataract surgery eye drop regimen used at Zuckerberg San Francisco General Hospital (ZSFG) is a significant burden for its patient population, contributing to high rates of non-adherence and the development of postoperative complications. The investigators propose to replace this complex regimen with a single administration of intraocular antibiotic and subconjunctival steroid at the time of surgery. This pilot study will obtain the preliminary data required to eventually fully evaluate this innovation in postoperative care in a safety-net population with respect to postoperative outcomes, patient compliance, and patient and caregiver satisfaction.
Conditions Studied
Interventions
- DRUG Dropless Regimen
- DRUG Standard Regimen
Study Locations (1)
California
- Zuckerberg San Francisco General Hospital and Trauma Center (ZSFG) - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2022-05-31 |
| Est. Completion | 2026-06-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05157113
The ClinicalTrials.gov registry entry for NCT05157113 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 52,851-participant average among 120 other Surgery trials with a reported enrollment target (100% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Surgery appearing as the primary indexed condition, and to 2 interventions - of which Dropless Regimen is the first listed.
NCT05157113 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05157113 about?
NCT05157113 is a clinical study titled "Evaluating a Dropless Postoperative Regimen After Cataract Surgery in a Vulnerable, County-hospital Population". The current postoperative cataract surgery eye drop regimen used at Zuckerberg San Francisco General Hospital (ZSFG) is a significant burden for its patient population, contributing to high rates of non-adherence and the development of postoperative complications. The investigators propose to replac...
What is the current status of trial NCT05157113?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 70 participants. The study started on 2022-05-31. Estimated completion is 2026-06-01.
What conditions does trial NCT05157113 study?
This clinical trial studies the following conditions: Surgery, Cataract, Satisfaction, Patient, Compliance, Patient, Compliance, Medication.
What interventions are being tested in trial NCT05157113?
The interventions under investigation include: Dropless Regimen (DRUG), Standard Regimen (DRUG).
Who is sponsoring clinical trial NCT05157113?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05157113 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Surgery
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial
RECRUITING · Phase 4
-
Continuous Versus Single Injection Adductor Canal Blocks for Outpatient Total Knee Arthroplasty
RECRUITING · Phase 4
-
Transversus Abdominis Plane Block Compared to Local Anesthetic Wound Infiltration in Gynecologic Oncology Surgery
RECRUITING · Phase 4
-
Comparing Analgesic Regimen Effectiveness and Safety for Surgery for Kids Trial
RECRUITING · Phase 4
-
Lovenox 30 mg Twice Daily (BID) Versus 40 mg Once Daily (QD)
RECRUITING · Phase 4
-
Multimodal Analgesia Effect on Post Surgical Patient
ACTIVE NOT RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.